Condition
Bicuspid Aortic Valve Disease
Total Trials
4
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Active Not Recruiting1
Not Yet Recruiting1
Recruiting1
Unknown1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07413965Not ApplicableNot Yet RecruitingPrimary
TAVR vs SAVR in Severe Bicuspid Aortic Stenosis
NCT01980797Active Not RecruitingPrimary
International Bicuspid Aortic Valve Consortium (BAVCon)
NCT06688448Not ApplicableRecruiting
Valvular Assessment of New Generation Aortic Replacement Devices
NCT05656820UnknownPrimary
Bicuspid Echocardiac Study Team（BEST）
Showing all 4 trials